Summary The kinetics, specificity and morphology of cytolethal responses have been studied in human glucocorticoid-sensitive and -insensitive lymphoid cell lines (HLCL) and fibroblasts following treatment with high (10-3 M) and low (10-6 M) doses of steroid. The high dose cytolethal response appears non-specific occurring in all cell lines with every steroid tested. By contrast, the low dose (pharmacological) cytolethal response requires an active glucocorticoid and a sensitive HLCL. However, both high and low concentrations of steroid induce virtually identical morphological changes in dying cells and similar changes can be induced in cells killed by deliberate feed exhaustion. Although the morphological features in each case resemble apoptosis, the "programmed" physiological form of cell death, the intracellular events leading to cytolysis seem likely to differ. The earliest morphological changes presaging cell death comprise rounding up of cells and condensation of nuclear chromatin. Nuclear changes progress rapidly thereafter and appear to result from detachment of chromatin from the nuclear matrix. The low dose cytolethal response requires the continuous presence of glucocorticoid for periods in excess of 24h, prior to which cell growth appears unaffected. The constancy of this latent interval suggests glucocorticoids may influence some replication control mechanism unrelated initially to macromolecular biosynthesis.
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Although glucocorticoid hormones are used extensively for treatment of human leukaemias and lymphomas (Schein et al., 1975; Simone, 1981) their therapeutic mode of action in man has still to be resolved. To elucidate the mechanisms involved human lymphoid cell lines (HLCL) have been employed as in vitro models for studies of glucocorticoid effects. However, unlike rodent thymocytes and lymphoid cell lines, HLCL are relatively resistant to the lethal actions of glucocorticoids and frequently require massive suprapharmacological concentrations of hormone to produce significant cytolethal responses (Bird et al., 1977; Burrow et al., 1981; Barrett et al., 1981) . Recently more sensitive HLCL have become available for investigation where cytolethal effects may be induced by lower, therapeutically attainable concentrations of hormone (Norman & Thompson, 1977) .
Previously we described the morphology of glucocorticoid-induced cell death in HLCL where suprapharmacological concentrations of hormone were applied to relatively resistant HLCL (Robertson et al., 1978) . Certain of the morphological features observed resembled apoptosis, the form of cell death occurring in situations where cell deletion is considered programmed Thompson, 1977) was cloned originally from a glucocorticoidinsensitive line CCRF-CEM established from a patient with acute lymphoblastic leukaemia (Foley et al, 1965 10-6 >90% <25% >90%
*Cytolethal response following treatment with steroid for 96 h as assessed by nigrosine exclusion (0.25%).
Steroid specificity As shown in Table II (Wode, 1977) , pharmacological doses of prednisolone should achieve in vivo concentrations of 10-6 M for up to 6 h following each treatment.
To stimulate such therapeutic practices glucocorticoid-sensitive lymphoid cells (CCRF-CEM-C7) were exposed to repeated 3 or 6 h daily pulses of MPSS at constant times each day. Employing this procedure the cytolethal response observed with continuous 10 6 M MPSS treatment is completely abolished (Figure 2 ). 
Morphology of cell death induced by high and low doses of glucocorticoid
The sequence of morphological changes following glucocorticoid treatment was studied by phase-, light-and electron-microscopy. The morphological sequence induced with high (10-3 M) or low (10-6 M) concentrations of glucocorticoid is identical irrespective of the cell type involved. Similar changes are seen also in cells dying as a result of deliberate feed exhaustion. Changes occur asynchronously within individual cultures and apparently unaffected cells co-exist for long periods (up to 72 h) alongside cells exhibiting advanced lethal changes.
The earliest changes comprise loss of the normal irregular surface contour (Figure 4 ) with roundingup of cells and the formation of a crescent or ring of condensed chromatin along the inner margin of the nuclear membrane ( Figure 5) low (pharmacological) dose effect, restricted to the sensitive lymphoid cell line (CCRF-CEM-C7) requires an active glucocorticoid and a hormone concentration (10-6M) that may be achieved during therapy. This concentration, however, still exceeds that required to saturate cytoplasmic glucocorticoid receptors and maximum physiological hormone levels (10-'M) which in these cell lines fails to induce cytolethal or cytostatic responses even when cells are continuously exposed to steroid for prolonged periods (up to 28 days). However, it seems likely the mode of action of glucocorticoids in vivo is complex and may involve both direct cytolethal actions as well as secondary effects mediated through influences on levels of growth factors (interleukins) and other mechanisms (Bird, 1979; Gillis et al., 1979; Krajewski & Wyllie, 1981; Paetkau, 1981) . The relatively higher concentration of glucocorticoid required for induction of cytolethal responses in vitro may reflect the absence of such secondary influences. Despite the difference in kinetics and specificity of high and low dose steroid effects the morphology of cell death in each case appears identical and closely resembles that described previously in glucocorticoid-resistant HLCL treated with high doses of steroid (Robertson et al., 1978) . Similar changes were also observed in cultures where cells were deliberately killed by feed exhaustion. Many of the ultrastructural changes observed resemble those described in apoptosis (Kerr et al., 1972) the form of cell death occurring in vivo where cell deletion is considered programmed . Although morphologically similar it seems unlikely that the intracellular events associated with apoptosis will be strictly comparable to those where cell death may be non-specific. Nonetheless HLCL remain valuable in vitro models for studying the effects of glucocorticoids on human lymphoid cells so long as pharmacologically-relevant concentrations of hormone (10-6 M) are employed, although the relevance for apoptosis of any changes demonstrated remains to be established.
Whatever nomenclature is applied to this form of cell death one of the earliest morphological features following glucocorticoid treatment is condensation of nuclear chromatin. Absence of demonstrable intermediate stages between early and late phases of this process suggests that once induced such changes progress rapidly. Normally chromatin is closely apposed and probably attached to the supporting protein substructure of the nucleus, termed the nuclear matrix (Agutter & Richardson, 1980) . Margination and condensation of chromatin implies either the nuclear matrix marginates or that chromatin becomes detached from it. The failure of nucleoli to change location within the condensed nuclei suggests the matrix remains unaltered and that condensation of chromatin results from the physical detachment of chromatin from the underlying matrix. There is evidence from studies with rat thymocytes treated with low doses of glucocorticoid that condensed chromatin is rapidly broken into short nucleosome chains by endogenous endonuclease (Wyllie, 1980) . It is not known whether this process is responsible also for the detachment of chromatin from the nuclear matrix or indeed what protects chromatin from endonucleases normally present in the nucleus. Activation of these endogenous enzymes may represent the first crucial step in the final common pathway of cytolethal responses.
The cause of the large surface protrusions seen in fresh suspensions and smears of glucocorticoidtreated cells is unknown. They are apparently delicate structures since they do not easily survive processing schedules and are found only with any frequency in fresh cell preparations. It is important to note they can also be induced artefactually in cells by over-vigorous smearing. They are probably not an early feature of cell death since cells manifesting these structures are permeable to vital dyes and show extensive condensation of nuclear chromatin. The demonstration of large amounts of Feulgen-positive material within protrusions suggests released DNA or other nuclear contents may play a part in their production. This might be achieved through some interaction with the cytoskeleton causing cell deformation. Alternatively, steroids may induce focal defects in the plasma membrane through which cytoplasmic contents may protrude. It is of interest therefore that apparent defects or 'holes' have been observed by scanning electron microscopy (SEM) in the plasma membrane of chronic lymphocytic leukaemia cells treated with glucocorticoids (Galili et al., 1982) . We have also observed similar membrane defects in SEM studies of our cell lines following steroid treatment (manuscript in preparation).
Induction of cytolethal effects with low (pharmacological) doses of glucocorticoid in the sensitive HLCL appears to require the continuous presence of steroid for over 24h. Discontinuous 3-6h daily pulses of glucocorticoid, comparable to therapeutic practices, proved ineffective in inducing cytolethal responses. Although the clinical relevance of this in vitro model of glucocorticoid-induced cell death requires further substantiation, the possibility that current therapeutic regimens may not be optimal for achieving maximal clinical responses should be considered. The timing of administration of other drugs used in combination with glucocorticoids also needs careful consideration (Gledhill & Norman, 1981) .
A constant feature of the low dose glucocorticoid response is the initial 24-36h latent interval prior to the onset of cytolethal effects. Briefer steroid exposure leaves cells apparently unscathed with growth rates indistinguishable from that of untreated controls. Further continuous exposure to steroid invariably leads to cell death in an asynchronous but steadily progressive manner until virtually every cell is affected by 96h. The critical intracellular events leading to the ultimate commitment to cell death are unknown but may relate to the progressive arrest of cells in the GI phase of the cell cycle (Harmon et al., 1979) . Since transition from Gl to S phase of the cell cycle represents a critical point of cell cycle regulation (Shields, 1977; Robinson et al., 1976) it seems possible that glucocorticoids progressively interfere with replication control at this stage. Further investigation of changes occurring within the first 24-36 h following steroid treatment clearly holds the key to understanding the mechanisms by which glucocorticoids induce cytolethal responses in human lymphoid cells.
